Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
N Engl J Med
.
2020 Aug 13;383(7):693-694.
doi: 10.1056/NEJMc2021840.
Authors
David Bomze
1
,
Tomer Meirson
2
,
Daniel Azoulay
3
Affiliations
1
Tel Aviv University, Tel Aviv, Israel davidbomze@mail.tau.ac.il.
2
Bar-Ilan University, Safed, Israel.
3
Hôpital Paul-Brousse, Villejuif, France.
PMID:
32786198
DOI:
10.1056/NEJMc2021840
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
atezolizumab